Senberk Pharmaceuticals Private Limited
About Senberk Pharmaceuticals Private Limited
Data last updated:
Senberk Pharmaceuticals Private Limited is a private limited company based in Cuttack, Odisha, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 20 January 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U33112OR2015PTC018628. Its GSTIN is 21AAVCS3716P1ZR (Odisha). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7 Lakh. It is led by directors including Biswa Ranjan Dash (Managing Director) and Sujit Kumar Singh.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Professor Para Sagadia Sahi Ranihat, Cuttack, Odisha, India – 753001.
As per the financials filed for FY 2024, the company reported a revenue of ₹32.55 Lakh, a decline of 45% compared to the previous year. For the same year it recorded a net loss of ₹10.93 Lakh (net margin -33.6%) and EBITDA of -₹10.51 Lakh (EBITDA margin -32.3%). Revenue has declined at a compounded annual rate (CAGR) of 30% over three years and 25% over five years.
Court records list 4 cases involving the company, including 4 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Senberk Pharmaceuticals Private Limited's registered office is in Cuttack, Odisha. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressProfessor Para Sagadia Sahi Ranihat, Cuttack, Odisha, India – 753001
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Senberk Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Senberk Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Senberk Pharmaceuticals Private Limited, buy the company report.
Financials of Senberk Pharmaceuticals Private Limited
FY 2024 filings availableSenberk Pharmaceuticals Private Limited reported revenue of ₹32.55 Lakh (down 45% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 25% over five years, including a 45% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹10.51 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹10.93 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -32.3% | ||||
| Net Profit Margin | -33.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Senberk Pharmaceuticals Private Limited, buy the company report.
Board of directors of Senberk Pharmaceuticals Private Limited
Senberk Pharmaceuticals has 4 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sujit Kumar Singh | Director | 20 Jan 2015 | 11 Years 9 Months | Current |
| Vijaya Choudhary | Director | 07 Jan 2019 | 7 Years 9 Months | Current |
| Arunjyoti Ghosal | Director | 20 Jan 2015 | 11 Years 9 Months | Current |
| Biswa Ranjan Dash Also directs: Fosen Pharmaceuticals Private Limited | Managing Director | 20 Jan 2015 | 11 Years 9 Months | Current |
Auditor
Senberk Pharmaceuticals Private Limited is audited by ROUTRAY AND CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ROUTRAY AND CO | FY 2017 | 0329060E |
Shareholding
The shareholding of Senberk Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Senberk Pharmaceuticals Private Limited, buy the company report.
Legal cases
Senberk Pharmaceuticals Private Limited has 4 court cases on record: 4 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 4 | 0 |
Cases on record (1 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Orissa | Writ petition | Filed against the company | Disposed |
To see the full case history of Senberk Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Senberk Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Senberk Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 01, 2024.
GST
Senberk Pharmaceuticals has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21AAVCS3716P1ZR | Odisha | Active | 01 Jul 2017 |
| 20AAVCS3716P1ZT | Jharkhand | Active | 11 Jul 2020 |
To see the full GST registrations and return filing status of Senberk Pharmaceuticals Private Limited, buy the company report.
Recent activity
Senberk Pharmaceuticals Private Limited has 10 board changes on record since 2015: 4 appointments and 6 cessations. The latest: Mukul Chatterjee ceased to be Director on 24 Feb 2022.
1 earlier event is in the company report.
Frequently asked questions
Senberk Pharmaceuticals is an active private limited company based in Cuttack, Odisha, India. The company works in chemical products, within the chemicals industry. It was incorporated on 20 January 2015 (11+ years old) and is registered under CIN U33112OR2015PTC018628.
Senberk Pharmaceuticals has 4 current directors:
- Biswa Ranjan Dash - Managing Director
- Sujit Kumar Singh - Director
- Vijaya Choudhary - Director
- Arunjyoti Ghosal - Director
The latest financial statements of Senberk Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Senberk Pharmaceuticals is 21AAVCS3716P1ZR, registered in Odisha. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 20AAVCS3716P1ZT (Jharkhand).
The CIN (Corporate Identification Number) of Senberk Pharmaceuticals is U33112OR2015PTC018628. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Senberk Pharmaceuticals has 4 court cases on record: 4 filed against it.
Senberk Pharmaceuticals was incorporated on 20 January 2015, making it 11+ years old. It is registered with the Registrar of Companies, Cuttack.
Mukul Chatterjee ceased to be Director on 24 Feb 2022. Ranjan Chatterjee ceased to be Director on 24 Feb 2022. Shiba Khatua Prasad ceased to be Director on 24 Feb 2022. Senberk Pharmaceuticals has 10 board changes on record in total.
The registered office of Senberk Pharmaceuticals is at Professor Para Sagadia Sahi Ranihat, Cuttack, Odisha, India – 753001.
Senberk Pharmaceuticals operates in the chemicals industry, in the chemical products segment.